ADMA Biologics Inc (ADMA)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 138,983 114,893 83,940 44,266 21,632 1,340 -16,662 -25,364 -39,366 -46,498 -51,618 -58,024 -58,373 -62,402 -61,766 -63,309 -64,915 -55,522 -50,771 -44,986
Revenue (ttm) US$ in thousands 426,454 382,809 330,245 283,177 258,216 234,293 208,108 181,890 154,079 130,481 110,072 93,998 80,944 68,517 58,112 48,069 42,220 40,301 37,248 36,021
Operating profit margin 32.59% 30.01% 25.42% 15.63% 8.38% 0.57% -8.01% -13.94% -25.55% -35.64% -46.89% -61.73% -72.12% -91.08% -106.29% -131.70% -153.75% -137.77% -136.31% -124.89%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $138,983K ÷ $426,454K
= 32.59%

The operating profit margin of ADMA Biologics Inc has shown a significant improvement over the analyzed period. Starting from a deeply negative margin of -124.89% in March 2020, the company's margin continued to worsen until hitting its lowest point of -153.75% in December 2020. However, a positive trend emerged thereafter, with a gradual reduction in the negative margin.

Subsequently, the company managed to reverse its performance, turning its operating profit margin positive from December 31, 2023, onwards. The margin improved steadily and consistently, reaching 32.59% by the end of December 31, 2024, indicating a remarkable recovery and profitability enhancement in the later periods.

This positive trajectory suggests that ADMA Biologics Inc effectively managed its operating costs, enhanced operational efficiency, and boosted revenue generation, thereby achieving sustainable profitability and financial health. Overall, the increasing trend in the operating profit margin reflects the company's successful turnaround and strengthened operational performance during the analyzed period.